Daniel Ek's Neko Health Secures $700 Million: A New Era in Body-Scanning Tech

Neko Health, the body-scanning and health assessment platform founded by Spotify co‑founder Daniel Ek and Hjalmar Nilsonne, has closed a $700 Million Series C round, marking the largest recent capital influx in the health‑tech space.

Funding Figures and Backers

■$700 Million new capital led by Lightspeed Venture Partners and O.G. Venture Partners.

■The preceding $260 Million Series B was raised in January 2025.

■Prominent investors such as Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD also participated.

Strategic Market Position

■With facilities in the United Kingdom and Sweden, Neko Health has built a solid European base and is preparing its first U.S. location in New York.

■The company reports over 100,000 scans completed and more than 350,000 individuals on its waitlist or appointment schedule.

■Integration with Apple Health converts personal data into clinical insights, creating a unique bridge within the digital health ecosystem.

Competition and Innovation

■Tech giants like MidJourney are also developing body‑scanning solutions, igniting a competitive race in the sector.

■Neko Health expands beyond medical diagnostics to serve gym enthusiasts with body‑composition and nutrition data, adopting a consumer‑centric approach.

Potential Impacts and Risks

■The funding boost can accelerate R&D, expanding AI‑driven diagnostic capabilities.

■Compliance with EU GDPR and US HIPAA regulations will be mandatory, posing regulatory challenges.

■Large‑scale data collection raises cybersecurity concerns, demanding robust risk‑management strategies from investors.

Captain Rıza Deniz: Neko Health's sizable capital raise should be seen as a pivot point for the health‑tech sector. Investor appetite signals a shift away from traditional maritime indicators like BDI and canal traffic, toward data flow and digital services as drivers of global trade volumes. Nevertheless, regulatory uncertainty and data‑security risks could cloud long‑term returns, warranting portfolio diversification and a cautious stance.